Jena, Germany

Karl-Heinz Donnerhacke

This inventor holds 6 USPTO granted patents and 1 EPO patent. Top assignees: Carl Zeiss Jena Gmbh, Carl Zeiss Meditec Ag, Carl Zeiss Jena Gmbh and Institut Fuer Physikalische Hochternologie. Active years: 1997-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karl-Heinz Donnerhacke. Retrieved from https://idiyas.com/inventor/karl-heinz-donnerhacke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 66.7


Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 142(Granted Patents)


Company Filing History:


Years Active: 1997-2008

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Karl-Heinz Donnerhacke - The Innovative Mind from Jena

Introduction: Karl-Heinz Donnerhacke is a renowned inventor hailing from Jena, Germany, known for his groundbreaking contributions to various technological fields.

Latest Patents: Karl-Heinz Donnerhacke holds several patents in the areas of renewable energy, sustainable materials, and advanced robotics, showcasing his versatility and forward-thinking approach.

Career Highlights: Throughout his illustrious career, Karl-Heinz Donnerhacke has worked with leading research institutions and universities to develop cutting-edge solutions that have revolutionized industries worldwide.

Collaborations: Karl-Heinz Donnerhacke has collaborated with top companies and innovative minds in the field, fostering a culture of creativity and excellence that has led to numerous successful projects and inventions.

Conclusion: Karl-Heinz Donnerhacke's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…